Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

22%

2 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

5(62.5%)

Phase 4

1(12.5%)

Phase 3

1(12.5%)

Phase 1

1(12.5%)

8Total

N/A(5)

Phase 4(1)

Phase 3(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT04227665Not ApplicableActive Not Recruiting

Identifying Biological Markers for Altitude Exposure and Use of Recombinant Human Erythropoietin (rHuEPO)

Role: collaborator

NCT03889834Not ApplicableCompleted

Biological Parameters Changes After Autologous Blood Transfusion of Red Blood Cells (200 ml) in Healthy Volunteers.

Role: collaborator

NCT06371963Completed

Relative Energy Deficiency in Sports (REDs) in Swedish Athletes

Role: collaborator

NCT04514978Not ApplicableUnknown

The Effect of Blood Donation on Hematological and Iron Indices and Detection of Autologous Blood Transfusion

Role: collaborator

NCT04203992Not ApplicableUnknown

Videogame for the Prevention of Doping and Supplement Abuse in Teenage Athletes

Role: collaborator

NCT03548766Phase 3Unknown

Using DNA-Typing and Erythrocyte Microparticle Analysis to Detect Blood Doping

Role: collaborator

NCT02869763Not ApplicableCompleted

Dose-response Effect of Alcohol Ingestion on Steroid Profile

Role: collaborator

NCT02779361Phase 1Completed

Effect of Tea Consumption on Steroid Profile in Healthy Volunteers

Role: collaborator

NCT01903785Phase 4Completed

Salbutamol, Pharmacogenetics and Breathing Mechanics

Role: collaborator

All 9 trials loaded